NIH funds $45 mn Alzheimer's drug development

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Sep, 2013

Singapore: The National Institutes of Health (NIH) is funding $45 million for research aimed at preventing Alzheimer's ...Read more

Singapore firm to launch next-gen cancer study device

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 May, 2014

Singapore: Singapore's emerging company Clearbridge BioMedics plans to launch its ClearCell FX System at American Societ...Read more

CSL files biologics license plea with FDA

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 4 Comment | 30 May, 2012

Singapore: The US Food and Drug Administration (FDA) has accepted Australia-based CSL Behring's biologics license applic...Read more

Japanese biomedical firm sets up lab in Singapore

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2013

Singapore: Japan-based biopharmaceutical firm, Kyowa Hakko Kirin (KHK) has setup Singapore Translational Research Labora...Read more

AB Sciex launches data analysis software

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2013

Singapore: AB Sciex, a global leader in analytical technologies, has launched MasterView Software, a new software applic...Read more

LCT conducts first implant of regenerative therapy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2013

Singapore: Australia-based Living Cell Technologies (LCT) has implanted regenerative cell therapy NTCELL, a treatment fo...Read more

GSK melanoma phase III misses co-primary endpoint

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2013

Singapore: GlaxoSmithKline's (GSK) Dermai study, a phase III, randomized, blinded, placebo-controlled Mage-A3 cancer imm...Read more

Bayer cancer drug Stivarga gets Singapore nod

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

Singapore: The Health Sciences Authority (HSA) of Singapore has approved Bayer' Stivarga, the first oral targeted therap...Read more

Eye diseases cost upto $27bn to Europe

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Oct, 2013

Singapore: European Forum Against Blindness (EFAB) has revealed the results of a six-country study which analyzed the ec...Read more

Gilead hepatitis drug to axe treatment time by half

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 09 Apr, 2013

Singapore: Gilead Sciences has submitted a New Drug Application (NDA) to the US FDA for approval of sofosbuvir, a once-d...Read more

Gilead leukemia study gets complete response

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 May, 2013

Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, ...Read more

Advinus collaborates with P2D Bioscience for ADHD

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2012

Bangalore: Advinus Therapeutics, a Bangalore-based drug discovery and development company, and P2D Bioscience, a CNS-foc...Read more

All you need to know about Glivec

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 01 Apr, 2013

What is Glivec?Glivec or imatinib mesylate is the first of a class of drugs that specifically inhibits a target enzyme, ...Read more

Cytomegalovirus treatments to improve

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 01 Feb, 2013

Singapore: A new report by healthcare experts GlobalData has revealed that on cytomegalovirus (CMV), which is generall...Read more

Sol-Gel to treat rosacea using acne drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

Singapore: Israel-based Sol-Gel Technologies achieved positive results for a phase II trial in the US targeting mild-to-...Read more

Phyto-pharmaceuticals to hit Indian markets soon

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Dec, 2013

Singapore: The Indian Ministry of Health and Family Welfare has notified the draft rules on a new domain of medicines ca...Read more

Novartis' thalassemia drug Exjade get EMA nod

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted...Read more

FDA scraps advisory committee on Merck's drug

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 17 Jul, 2013

Singapore: The US FDA has cancelled an advisory committee meeting that was scheduled to be held on July 18, 2013, in ord...Read more